Log In
BCIQ
Print this Print this
 

tecarfarin (formerly ATI-5923)

  Manage Alerts
Collapse Summary General Information
Company Armetheon Inc.
DescriptionLong-acting inhibitor of vitamin K epoxide reductase complex subunit 1 (VKORC1)
Molecular Target Vitamin K epoxide reductase complex subunit 1 (VKORC1)
Mechanism of ActionVitamin K epoxide reductase complex subunit 1 (VKORC1) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II/III
Standard IndicationBlood clots
Indication DetailsPrevent blood clots; Prevent blood clots in patients with atrial fibrillation (AF)
Regulatory Designation U.S. - Special Protocol Assessment (Prevent blood clots)
PartnerLee's Pharmaceutical Holdings Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

09/22/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today